Dcd Liver Preservation

Warm ischemia makes timing and preservation conditions central to DCD liver quality. During this interval, the graft can become more vulnerable to later ischemia-reperfusion injury, so preservation must address more than storage alone. Combining controlled cold conditions with active perfusion aims to support viability despite the initial insult and provides a basis for evaluating whether the liver remains suitable for transplantation.

During machine perfusion, an oxygenated preservation solution supplies substrates and removes waste as it circulates through the liver. This creates active support for the graft while it is outside the body. The same setup links preservation with assessment, because the perfused organ can provide measurable indicators used to judge retained viability before transplantation.

Controlled cold storage and machine perfusion provide complementary preservation functions. Cold storage supplies a controlled preservation condition, whereas perfusion actively circulates an oxygenated solution through the liver. Using both approaches can support viability while also creating an opportunity to assess the graft, which is especially important when warm ischemia has made quality less certain.

Measurable viability indicators help convert preservation from a storage decision into an evidence-based suitability decision. Rather than relying only on the donation context, the transplant team can use information generated during preservation to judge whether the graft appears viable. This supports more individualized decisions about acceptance and may improve transplant safety when graft quality is uncertain.

A typical workflow combines controlled cold storage with machine perfusion and evaluation before transplantation. The liver is maintained under controlled preservation conditions and supported by circulation of an oxygenated solution through the graft, while measurable indicators are considered before a suitability decision. This connects physical preservation with functional assessment rather than treating storage as the final endpoint.

DCD liver preservation is particularly relevant when clinicians are considering marginal grafts, whose quality may be less certain after warm ischemia. By supporting viability and generating information before transplantation, these methods may expand the donor pool without removing the need for individualized suitability decisions. Their value lies in helping balance broader organ availability with transplant safety.